José Federico Díaz González-rekin lankidetzan egindako argitalpenak (8)

2021

  1. Differences in Capacity of High-Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Arthritis Care and Research, Vol. 73, Núm. 11, pp. 1590-1596

  2. HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis

    Arthritis Research and Therapy, Vol. 23, Núm. 1

2020

  1. HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients

    Clinical Rheumatology, Vol. 39, Núm. 6, pp. 1871-1880

  2. Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis

    Rheumatology (Oxford, England), Vol. 59, Núm. 10, pp. 2847-2856

2019

  1. Effect of IL-6 Receptor Blockade on Proprotein Convertase Subtilisin/Kexin Type-9 and Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients

    Hormone and Metabolic Research, Vol. 51, Núm. 3, pp. 200-209

2017

  1. Functional effects of proinflammatory factors present in Sjogren's syndrome salivary microenvironment in an in vitro model of human salivary gland

    Scientific Reports, Vol. 7, Núm. 1

  2. HDL cholesterol efflux capacity in rheumatoid arthritis patients: Contributing factors and relationship with subclinical atherosclerosis

    Arthritis Research and Therapy, Vol. 19, Núm. 1

2014

  1. Prevention of neutrophil extravasation by α2-Adrenoceptor-mediated endothelial stabilization

    Journal of Immunology, Vol. 193, Núm. 6, pp. 3023-3035